KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hims & Hers Health (HIMS) Operating Expenses: 2020-2025

Historic Operating Expenses for Hims & Hers Health (HIMS) over the last 6 years, with Sep 2025 value amounting to $430.3 million.

  • Hims & Hers Health's Operating Expenses rose 45.60% to $430.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 59.99%. This contributed to the annual value of $1.1 billion for FY2024, which is 49.28% up from last year.
  • As of Q3 2025, Hims & Hers Health's Operating Expenses stood at $430.3 million, which was up 10.47% from $389.5 million recorded in Q2 2025.
  • In the past 5 years, Hims & Hers Health's Operating Expenses ranged from a high of $430.3 million in Q3 2025 and a low of $64.7 million during Q2 2021.
  • For the 3-year period, Hims & Hers Health's Operating Expenses averaged around $277.1 million, with its median value being $245.6 million (2024).
  • Data for Hims & Hers Health's Operating Expenses shows a peak YoY surged of 230.35% (in 2021) over the last 5 years.
  • Hims & Hers Health's Operating Expenses (Quarterly) stood at $83.7 million in 2021, then skyrocketed by 72.05% to $143.9 million in 2022, then surged by 42.04% to $204.5 million in 2023, then soared by 71.65% to $350.9 million in 2024, then surged by 45.60% to $430.3 million in 2025.
  • Its Operating Expenses was $430.3 million in Q3 2025, compared to $389.5 million in Q2 2025 and $372.8 million in Q1 2025.